Promising Results for Chemo-Free Immunotherapy in Early-Stage Triple-Negative Breast Cancer
Phase 2 trial shows potential for immunotherapy without chemo in early TNBC, especially with high TILs.
Multiple Myeloma
4 articles
Acyclovir Prophylaxis Slashes Mucositis Risk in Stem Cell Transplant Patients
Study shows acyclovir prophylaxis significantly reduces oral mucositis in autologous stem cell transplants.
Aponermin Plus Standard Therapy Shows Promise for Relapsed Multiple Myeloma
Phase 3 trial finds aponermin combination improves outcomes in relapsed/refractory multiple myeloma patients
Daratumumab Combo Shows Promise for Relapsed Multiple Myeloma
Study finds adding daratumumab to pomalidomide and dexamethasone improves survival in multiple myeloma
New Myeloma Treatment Shows Promise, But Falls Short of Expectations
Study finds belantamab mafodotin matches standard therapy for multiple myeloma, with fewer infections